索引于
  • 学术期刊数据库
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 中国知网(CNKI)
  • 引用因子
  • 西马戈
  • 乌尔里希的期刊目录
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-WorldCat
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Bioequivalence Significance and Its Utilizes

Macroni Laco

The FDA keeps up that affirmed conventional medications are comparable to their marked partners, bioequivalence issues have been accounted for by doctors and patients for some medications. Certain classes of medications are associated to be especially dangerous in light of the fact that with their science. A portion of these incorporate chiral drugs, inadequately assimilated drugs, and cytotoxic medications. Moreover, complex conveyance systems can cause bioequivalence differences. Doctors are advised to try not to change patients from marked to conventional, or between various nonexclusive producers, while endorsing against epileptic medications, warfarin, and levothyroxine.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证